Receptor.AI is a next-generation TechBio company revolutionizing drug discovery with a multiplatform AI-powered ecosystem. We specialize in designing small molecules, peptides, and drug conjugates, accelerating the development of novel therapies for challenging targets.



Our ecosystem features dedicated platforms for Induced Proximity, Drug Conjugates, and Monofunctional Compounds built on rigorous validation. These platforms are based on technologies such as leading AI-docking model ArtiDock, proprietary PPI prediction AI model surpassing AlphaFold-Multimer, and dozens of experimentally validated AI models tailored for specific cases in drug design.



With a portfolio of >40 projects and an overall success rate of 85%, Receptor.AI is making a tangible impact in drug discovery. By partnering with the leaders in BioTech and Top-10 Big Pharma we continuously refine and advance our AI drug-discovery ecosystem to tackle the most complex therapeutic challenges.



At Receptor.AI, our team of seasoned scientists, engineers, and industry experts is dedicated to revolutionizing drug discovery with combined expertise and shared vision.